Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Bristol Myers Squibb this week announced a partnership with Hengrui Pharma to develop drugs together. American and European biopharmaceutical companies are increasingly looking to China for their next blockbusters.
Open original source